NOT-HG-20-051: Notice of Early Expiration of PAR-18-735 (Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) and PAR-18-736 (Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)

Notice of Early Expiration of PAR-18-735 (Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) and PAR-18-736 (Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)

Notice Number:

NOT-HG-20-051

Key Dates

Release Date:

July 2, 2020

Related Announcements

PAR-18-735 - Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional)

PAR-18-736 - Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)

RFA-HG-20-036 - Advancing Genomic Medicine Research (R01 Clinical Trial Optional)

RFA-HG-20-037 - Advancing Genomic Medicine Research (R21 Clinical Trial Optional)

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to inform the extramural community that PAR-18-735 (Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) and PAR-18-736 (Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional) will expire immediately.

In place of PAR-18-735 and PAR-18-736, NHGRI has issued RFA-HG-20-036 (Advancing Genomic Medicine Research (Clinical Trial Optional) (R01) and RFA-HG-20-037 (Advancing Genomic Medicine Research (Clinical Trial Optional) (R21).

This Notice is effective immediately.

Inquiries

Please direct all inquiries to:

Ms. Christine Chang

National Human Genome Research Institute (NHGRI)
Telephone: 301-480-2255
Email:[email protected]